Evidence map›Paper›PMID 41664475›Full record

Trial reportHealth technology assessment (Winchester, England)2026

Conservative versus liberal oxygenation targets in critically ill children: the Oxy-PICU RCT.

Doug Gould, Samiran Ray, Irene Chang, Elisa Giallongo, Marzena Orzol, Lauran O'Neill, Rachel Agbeko, Carly Au, Elizabeth Draper, Lee Elliot-Major and 14 more

Abstract readRandomized Controlled TrialMulticenter StudyPragmatic Clinical Trial
In one paragraph

Trial report in Health technology assessment (Winchester, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Doug GouldClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.ORCID 0000-0003-4148-3312
Samiran RayPaediatric Intensive Care Unit, Great Ormond Street Hospital for Children NHS Foundation Trust and NIHR Biomedical Research Centre, London, UK.ORCID 0000-0002-3738-4672
Irene ChangClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.ORCID 0000-0002-1228-0260
Elisa GiallongoClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.ORCID 0000-0002-3697-5999
Marzena OrzolClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.ORCID 0000-0001-6624-5041
Lauran O'NeillPaediatric Intensive Care Unit, Great Ormond Street Hospital for Children NHS Foundation Trust and NIHR Biomedical Research Centre, London, UK.ORCID 0000-0003-1099-024X
Rachel AgbekoDepartment of Paediatric Intensive Care, Great North Children's Hospital, The Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.ORCID 0000-0001-8931-6869
Carly AuClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.ORCID 0000-0003-1385-9239
Elizabeth DraperDepartment of Population Health Sciences, University of Leicester, Leicester, UK.ORCID 0000-0001-9340-8176
Lee Elliot-MajorParent representative, London, UK.ORCID 0000-0002-1542-1698
Gareth JonesPaediatric Intensive Care Unit, Great Ormond Street Hospital for Children NHS Foundation Trust and NIHR Biomedical Research Centre, London, UK.ORCID 0000-0002-9193-2609
Lamprini LamproClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.ORCID 0009-0003-9639-3303
Jon LilliePaediatric Intensive Care Unit, Evelina London Children's Hospital, London, UK.ORCID 0000-0003-1776-5184
John PappachanPaediatric Intensive Care Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK.ORCID 0000-0002-3559-0595
Samiran PetersClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.
Padmanabhan RamnarayanSection of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.ORCID 0000-0003-0784-8154
Zia SadiqueDepartment of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0001-5814-0258
Karen ThomasClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.ORCID 0000-0001-7548-4466
Silvia Moler-ZapataDepartment of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0003-4733-5601
Kathryn RowanClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.ORCID 0000-0001-8217-5602
David HarrisonClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.ORCID 0000-0002-9002-9098
Paul MounceyClinical Trials Unit, Intensive Care National Audit & Research Centre, London, UK.ORCID 0000-0002-8510-8517
Mark PetersPaediatric Intensive Care Unit, Great Ormond Street Hospital for Children NHS Foundation Trust and NIHR Biomedical Research Centre, London, UK.ORCID 0000-0003-3653-4808
Oxy-PICU Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The optimal target for systemic oxygenation in critically ill children is unknown. Liberal oxygenation is widely practised but is associated with harm in observational studies. Objectives: To evaluate the clinical and cost-effectiveness of a conservative oxygenation target of peripheral oxygen saturation 88-92% compared with peripheral oxygen saturation > 94% in critically ill children admitted to paediatric intensive care unit as an emergency. Design and setting: A pragmatic, open, multicentre, parallel-group, randomised clinical trial conducted in 15 National Health Service paediatric intensive care units and associated emergency transport services across England and Scotland. Participants: Children aged > 38 weeks corrected gestational age and < 16 years, enrolled within 6 hours of being accepted for admission to paediatric intensive care unit as an emergency; receiving invasive mechanical ventilation with supplemental oxygen; and in face-to-face contact with paediatric intensive care unit or emergency transport services staff. Interventions: Adjustment of ventilator and inspired oxygen settings aiming to achieve peripheral oxygen saturation 88-92% (conservative oxygenation) or peripheral oxygen saturation > 94% (liberal oxygenation) during invasive mechanical ventilation. Main outcome measures: Primary outcomes: duration of organ support at 30 days, with death by day 30 ranked as the worst outcome (clinical effectiveness) and incremental costs, quality-adjusted life-years and net monetary benefit at 12 months (cost-effectiveness). Secondary outcomes: incremental costs at 30 days; mortality at paediatric intensive care unit discharge, 30 days, 90 days and 12 months; time to liberation from ventilation; duration of organ support; length of paediatric intensive care unit and hospital stay; functional status at paediatric intensive care unit discharge; and health-related quality of life at 12 months. Results: Two thousand and forty children were randomised between 1 September 2020 and 15 May 2022. Consent was obtained for 1872 (94%) - 939 to the conservative and 933 to the liberal oxygenation group - who were included in the primary analysis. Duration of organ support or death in the first 30 days was lower in the conservative oxygenation group [probabilistic index 0.53, 95% confidence interval 0.50 to 0.55; Limitations: Exclusion of two large paediatric intensive care unit populations, due to a lack of equipoise and the number of participants excluded because of not being able to obtain deferred consent. Future work: Future work should focus on identification of the mechanisms underlying the observed benefit; trials of intermediate or lower peripheral oxygen saturation values in individuals at higher risk; and identification of individualised treatment effects in relation to oxygen therapy. Conclusions: A conservative oxygenation target resulted in a greater probability of a better outcome in terms of duration of organ support at 30 days or death. Longer-term survival and health-related quality of life were consistent with the primary outcome. While conservative oxygenation is likely to reduce costs in the short term, longer-term cost-effectiveness was surrounded with wide uncertainty. Funding: This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR127547.

Indexed as

Critical IllnessIntensive Care Units, PediatricOxygenOxygen Inhalation TherapyOxygen SaturationRespiration, ArtificialAdolescentChildChild, PreschoolCost-Benefit AnalysisCost-Effectiveness AnalysisEnglandFemaleHumansInfantMaleOxygenINVASIVE VENTILATIONOXYGENPAEDIATRIC INTENSIVE CAREPICURANDOMISED CLINICAL TRIAL

Identifiers

PMID41664475
PMCPMC12907991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.